N2-Tritylolmesartan medoxomil is a trityl-protected intermediate in the synthesis of olmesartan medoxomil, an angiotensin II receptor antagonist. Its structure incorporates a triphenylmethyl (trityl) protecting group on the tetrazole ring, which is later removed to yield the active pharmaceutical ingredient.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1020157-01-0
Tritylolmesartan medoxomil
Pharmaceutical intermediate for olmesartan medoxomil
N-Trityl Olmesartan Ethyl Ester
pharmaceutical intermediate
Olmésartan médoxomil
active pharmaceutical ingredient
2-(4-Biphenylyl)-4,6-dichloro-1,3,5-triazine
n.a
3,5-Dichlorobenzaldehyde
n.a
2-(3-methoxyphenyl)-1,1-dioxo-2H-1??-thieno(3,2-e)(1,2)thiazine-6-sulfonamide
n.a
2,3-dimethoxy-7,7-dimethyl-9-trifluoromethyl-7H-benzo[C]fluoren-5-ol
n.a
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
KKYFOXOGKNDKRS-UHFFFAOYSA-N
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN(N=N4)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)OCC8=C(OC(=O)O8)C)C(C)(C)O